NSPc1 is a cell growth regulator that acts as a transcriptional repressor of p21Waf1/Cip1 via the RARE element

被引:34
|
作者
Gong, Yanhua
Yue, Jiping
Wu, Xudong
Wang, Xu
Wen, Jianyan
Lu, Lifang
Peng, Xiaozhong [1 ]
Qiang, Boqin
Yuan, Jiangang
机构
[1] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100005, Peoples R China
[2] Peking Union Med Coll, Natl Human Genome Ctr, Beijing 1000005, Peoples R China
[3] Shanghai Genom Inc, Shanghai 201203, Peoples R China
关键词
D O I
10.1093/nar/gkl834
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mammalian polycomb group proteins play an important role in cell cycle control and tumorigenesis. Nervous system polycomb 1 (NSPc1) is a newly identified transcription repressor, highly homologous with PcG protein Bmi-1. In this article, we showed that NSPc1 could promote tumor cell cycle progression and cell proliferation. Semi-quantitative RT-PCR showed that NSPc1 did not affect the expression levels of most Cyclin-depentent kinases (CDK) inhibitors except for p21Waf1/Cip1. Repression activity assays, chromatin immunoprecipitation (ChIP) and DNA pulldown assays all verified that NSPc1 represses the expression of p21Waf1/Cip1 by binding to the (-1357 to -1083) region of the p21Waf1/Cip1 promoter in vivo, and the repression effect is dependent on the retinoid acid response element (RARE element) within the above region of the p21Waf1/Cip1 promoter. Further analysis showed that NSPc1 could compete the RARE element site with RA receptors both in vitro and in vivo. Taken together, our results support the hypothesis that NSPc1 has a positive role in tumor cell growth by down-regulating p21Waf1/Cip1 via the RARE element, which directly connects transcriptional repression of PcGs to CDKIs and RA signaling pathways.
引用
收藏
页码:6158 / 6169
页数:12
相关论文
共 50 条
  • [41] Suppression of breast cancer growth and angiogenesis by an antisense oligodeoxynucleotide to p21Waf1/Cip1
    Weiss, RH
    Marshall, D
    Howard, L
    Corbacho, AM
    Cheung, AT
    Sawai, ET
    CANCER LETTERS, 2003, 189 (01) : 39 - 48
  • [42] p21WAF1/CIP1 gene transcriptional activation exerts cell growth inhibition and enhances chemosensitivity to cisplatin in lung carcinoma cell
    Wei, Junxia
    Zhao, Jiang
    Long, Min
    Han, Yuan
    Wang, Xi
    Lin, Fang
    Ren, Jihong
    He, Ting
    Zhang, Huizhong
    BMC CANCER, 2010, 10
  • [43] AP2 inhibits cancer cell growth and activates p21WAF1/CIP1 expression
    Yi-Xin Zeng
    Kumaravel Somasundaram
    Wafik S. El-Deiry
    Nature Genetics, 1997, 15 : 78 - 82
  • [44] p21WAF1/CIP1 may be a tumor suppressor after all
    Gartel, Andrei L.
    CANCER BIOLOGY & THERAPY, 2007, 6 (08) : 1171 - 1172
  • [45] p21WAF1/CIP1在肺癌中的表达
    丁焕然
    马小兵
    中国煤炭工业医学杂志, 2007, (07) : 827 - 828
  • [46] Regulation of p21waf1/cip1 expression by intracellular redox conditions
    Esposito, F
    Russo, L
    Chirico, G
    Ammendola, R
    Russo, T
    Cimino, F
    IUBMB LIFE, 2001, 52 (1-2) : 67 - 70
  • [47] p21WAF1/CIP1 protein expression in primary ovarian cancer
    Ferrandina, G
    Stoler, A
    Fagotti, A
    Fanfani, F
    Sacco, R
    De Pasqua, A
    Mancuso, S
    Scambia, G
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2000, 17 (06) : 1231 - 1235
  • [48] Influence of Ras and Rho on p21Waf1/Cip1 protein stability
    Coleman, M
    Marshall, CJ
    Olson, MF
    MOLECULAR MECHANISMS OF SIGNAL TRANSDUCTION, 2000, 316 : 39 - 49
  • [49] Overexpression of p21WAF1/CIP1 induces cell differentiation and growth inhibition in a human glioma cell line
    Kokunai, T
    Izawa, I
    Tamaki, N
    INTERNATIONAL JOURNAL OF CANCER, 1998, 75 (04) : 643 - 648
  • [50] Cell cycle arrest and DNA endoreduplication following p21Waf1/Cip1 expression
    Stewart Bates
    Kevin M Ryan
    Andrew C Phillips
    Karen H Vousden
    Oncogene, 1998, 17 : 1691 - 1703